[11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

[11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain. / Marthi, Katalin; Bender, Dirk; Gjedde, Albert; Smith, Donald F.

In: European Neuropsychopharmacology, Vol. 12, No. 5, 2002, p. 427-32.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Marthi, K, Bender, D, Gjedde, A & Smith, DF 2002, '[11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain', European Neuropsychopharmacology, vol. 12, no. 5, pp. 427-32.

APA

Marthi, K., Bender, D., Gjedde, A., & Smith, D. F. (2002). [11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain. European Neuropsychopharmacology, 12(5), 427-32.

Vancouver

Marthi K, Bender D, Gjedde A, Smith DF. [11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain. European Neuropsychopharmacology. 2002;12(5):427-32.

Author

Marthi, Katalin ; Bender, Dirk ; Gjedde, Albert ; Smith, Donald F. / [11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain. In: European Neuropsychopharmacology. 2002 ; Vol. 12, No. 5. pp. 427-32.

Bibtex

@article{353bf320b31511debc73000ea68e967b,
title = "[11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain",
abstract = "We radiolabelled mirtazapine, a tetracyclic, atypical, antidepressant drug, for positron emission tomography (PET) and evaluated its regional kinetics in the living porcine brain. We produced [N-methyl-11C]mirtazapine with a radiochemical-purity >98% in a 21% decay-corrected radiochemical yield by alkylation of N-desmethyl mirtazapine with [11C]methyl iodide, followed by HPLC purification and formulation. [N-Methyl-11C]mirtazapine entered the brain readily and, under baseline conditions, it had an apparent volume of distribution (V(e)') of 9-13 in the basal ganglia, thalamus, and frontal cortex. Reference region and graphical analyses based on a one-compartment model showed that the binding of [N-methyl-11C]mirtazapine was reversible, with an apparent binding potential of more than two in thalamus and frontal cortex. Infusion of unlabelled mirtazapine markedly displaced [N-methyl-11C]mirtazapine from binding sites in the basal ganglia, thalamus and frontal cortex, but not in reference regions (cerebellum and olfactory tubercle). Thus, [N-methyl-11C]mirtazapine showed rapid passage into the living brain, slow metabolism in blood, and reversible, competitive binding, which may make it useful for PET neuroimaging of neuroreceptors involved in antidepressant actions.",
author = "Katalin Marthi and Dirk Bender and Albert Gjedde and Smith, {Donald F}",
year = "2002",
language = "English",
volume = "12",
pages = "427--32",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",
number = "5",

}

RIS

TY - JOUR

T1 - [11C]Mirtazapine for PET neuroimaging: radiosynthesis and initial evaluation in the living porcine brain

AU - Marthi, Katalin

AU - Bender, Dirk

AU - Gjedde, Albert

AU - Smith, Donald F

PY - 2002

Y1 - 2002

N2 - We radiolabelled mirtazapine, a tetracyclic, atypical, antidepressant drug, for positron emission tomography (PET) and evaluated its regional kinetics in the living porcine brain. We produced [N-methyl-11C]mirtazapine with a radiochemical-purity >98% in a 21% decay-corrected radiochemical yield by alkylation of N-desmethyl mirtazapine with [11C]methyl iodide, followed by HPLC purification and formulation. [N-Methyl-11C]mirtazapine entered the brain readily and, under baseline conditions, it had an apparent volume of distribution (V(e)') of 9-13 in the basal ganglia, thalamus, and frontal cortex. Reference region and graphical analyses based on a one-compartment model showed that the binding of [N-methyl-11C]mirtazapine was reversible, with an apparent binding potential of more than two in thalamus and frontal cortex. Infusion of unlabelled mirtazapine markedly displaced [N-methyl-11C]mirtazapine from binding sites in the basal ganglia, thalamus and frontal cortex, but not in reference regions (cerebellum and olfactory tubercle). Thus, [N-methyl-11C]mirtazapine showed rapid passage into the living brain, slow metabolism in blood, and reversible, competitive binding, which may make it useful for PET neuroimaging of neuroreceptors involved in antidepressant actions.

AB - We radiolabelled mirtazapine, a tetracyclic, atypical, antidepressant drug, for positron emission tomography (PET) and evaluated its regional kinetics in the living porcine brain. We produced [N-methyl-11C]mirtazapine with a radiochemical-purity >98% in a 21% decay-corrected radiochemical yield by alkylation of N-desmethyl mirtazapine with [11C]methyl iodide, followed by HPLC purification and formulation. [N-Methyl-11C]mirtazapine entered the brain readily and, under baseline conditions, it had an apparent volume of distribution (V(e)') of 9-13 in the basal ganglia, thalamus, and frontal cortex. Reference region and graphical analyses based on a one-compartment model showed that the binding of [N-methyl-11C]mirtazapine was reversible, with an apparent binding potential of more than two in thalamus and frontal cortex. Infusion of unlabelled mirtazapine markedly displaced [N-methyl-11C]mirtazapine from binding sites in the basal ganglia, thalamus and frontal cortex, but not in reference regions (cerebellum and olfactory tubercle). Thus, [N-methyl-11C]mirtazapine showed rapid passage into the living brain, slow metabolism in blood, and reversible, competitive binding, which may make it useful for PET neuroimaging of neuroreceptors involved in antidepressant actions.

M3 - Journal article

C2 - 12208560

VL - 12

SP - 427

EP - 432

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

IS - 5

ER -

ID: 14946068